DrugDashboards

Testosterone

Testosterone · TESTOSTERONE 25 mg/2.5g · Gel · Transdermal · Strides Pharma Science Limited

NDC 64380-0151-02 · 30 DOSE PACK in 1 CARTON / 2.5 g in 1 DOSE PACK · ANDA · View full market →

The short version

11 companies supply this market — deep enough that no single failure threatens the supply. The generic price is down 21% over the past year, to $1.14 per gram. The brand (Testim) runs $3.78 per gram — 5.2× more. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$1.14per GMinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$1.21per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$1.88per unitAvKare, LLC · Jun 15, 2023165% of what pharmacies pay — higher than 71% of drugs with this benchmark
  • Medicaid generic ceiling (FUL)$1.14per GMweighted avg manufacturer price $0.2500 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00$3.00Aug 2022Sep 2026$1.14
50 price points · per GM · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

WAC per package, as filed
$180.00
Reported to Texas DSHS · 2026 annual filing · Strides Pharma Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$173,075
1,139 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

8● Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • price down 29% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for testosterone (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA076744
TE code
AB1
Approval date
May 23, 2007
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · OngoingMar 5, 2025
    Strides Pharma, Inc. — Presence of foreign substance: Presence of Benzene.
  • Class II · OngoingMar 5, 2025
    Strides Pharma, Inc. — Presence of foreign substance: Presence of Benzene.

Manufacturers of Testosterone (Gel)

LabelerStrengthFirst seenLast seen
Actavis Pharma, Inc.TESTOSTERONE 10 mg/gJul 15, 2026Sep 3, 2026
Actavis Pharma, Inc.TESTOSTERONE 16.2 mg/gJul 15, 2026Sep 3, 2026
Prasco LaboratoriesTESTOSTERONE 16.2 mg/gJul 15, 2026Sep 3, 2026
Upsher-Smith Laboratories, LLCTESTOSTERONE 50 mg/5gJul 15, 2026Sep 3, 2026
Actavis Pharma, Inc.TESTOSTERONE 50 mg/5gJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.TESTOSTERONE 16.2 mg/gJul 15, 2026Sep 2, 2026
Encube Ethicals, Inc.TESTOSTERONE 16.2 mg/gJul 15, 2026Sep 2, 2026
Endo USA, Inc.TESTOSTERONE 50 mg/5gJul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.TESTOSTERONE 16.2 mg/gJul 15, 2026Sep 2, 2026
Northstar Rx LLCTESTOSTERONE 20.25 mg/1.25gJul 15, 2026Sep 2, 2026
Northstar Rx LLCTESTOSTERONE 40.5 mg/2.5gJul 15, 2026Sep 2, 2026
Padagis Israel Pharmaceuticals LtdTESTOSTERONE 40.5 mg/2.5gJul 15, 2026Sep 2, 2026
Padagis Israel Pharmaceuticals LtdTESTOSTERONE 16.2 mg/gJul 15, 2026Sep 2, 2026
Padagis Israel Pharmaceuticals LtdTESTOSTERONE 20.25 mg/1.25gJul 15, 2026Sep 2, 2026
Prasco LaboratoriesTESTOSTERONE 12.5 mg/1.25gJul 15, 2026Sep 2, 2026
Prasco LaboratoriesTESTOSTERONE 25 mg/2.5gJul 15, 2026Sep 2, 2026
Prasco LaboratoriesTESTOSTERONE 50 mg/5gJul 15, 2026Sep 2, 2026
Strides Pharma Science LimitedTESTOSTERONE 50 mg/5gJul 15, 2026Sep 2, 2026
Strides Pharma Science LimitedTESTOSTERONE 25 mg/2.5gJul 15, 2026Sep 2, 2026
Bryant Ranch PrepackTESTOSTERONE 16.2 mg/gJul 15, 2026Aug 31, 2026
ASCEND Therapeutics U.S., LLCTESTOSTERONE 10 mg/gJul 15, 2026Jul 30, 2026
ASCEND Therapeutics U.S., LLCTESTOSTERONE 16.2 mg/gJul 15, 2026Jul 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Testosterone — NDC 64380-0151-02," retrieved September 3, 2026, https://drugdashboards.com/drug/64380015102.

Free to cite with attribution — see how the data is put together.